Evidence map›Paper›PMID 29445231›Full record

ArticleScientific reports2018

Impact of nanoparticles on the Bacillus subtilis (3610) competence.

Elise Eymard-Vernain, Sylvie Luche, Thierry Rabilloud, Cécile Lelong

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Strain-SpecificInternational journal of nanomedicine · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Effect of TiOBiological trace element research · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elise Eymard-VernainUniversité Grenoble Alpes, CNRS, CEA, BIG, CBM, 17 avenue des Martyrs, 38054, Grenoble cedex 9, France.
Sylvie LucheUniversité Grenoble Alpes, CNRS, CEA, BIG, CBM, 17 avenue des Martyrs, 38054, Grenoble cedex 9, France.
Thierry RabilloudUniversité Grenoble Alpes, CNRS, CEA, BIG, CBM, 17 avenue des Martyrs, 38054, Grenoble cedex 9, France.ORCID 0000-0002-4372-5218
Cécile LelongUniversité Grenoble Alpes, CNRS, CEA, BIG, CBM, 17 avenue des Martyrs, 38054, Grenoble cedex 9, France. cecile.lelong@univ-grenoble-alpes.fr.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the physicochemical properties of nanoparticles, the use of nanomaterials increases every year in industrial and medical processes. At the same time, the increasing number of bacteria becoming resistant to many antibiotics, mostly by a horizontal gene transfer process, is a major public health concern. We herein report, for the first time, the role of nanoparticles in the physiological induction of horizontal gene transfer in bacteria. Besides the most well-known impacts of nanoparticles on bacteria, i.e. death or oxidative stress, two nanoparticles, n-ZnO and n-TiO

Indexed as

DNA Transformation CompetenceAdaptation, PhysiologicalAnti-Bacterial AgentsATP-Binding Cassette TransportersBacillus subtilisBacterial ProteinsBiofilmsDrug Resistance, MicrobialGene Expression Regulation, BacterialGene Transfer, HorizontalNanoparticlesTitaniumTransformation, BacterialZinc OxideAnti-Bacterial AgentsATP-Binding Cassette TransportersBacterial ProteinsTitaniumtitanium dioxideZinc Oxide

Identifiers

PMID29445231
PMCPMC5813000
OpenAlexW2794482790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.